The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of cetuximab in 1st-line therapy for metastatic colorectal cancer (mCRC) according to tumor RAS/BRAF mutation (mt) status in the EREBUS cohort.
 
Denis Michel Smith
No Relationships to Disclose
 
Magali Rouyer
No Relationships to Disclose
 
Eric Francois
Consulting or Advisory Role - Merck; Roche
Travel, Accommodations, Expenses - Merck; Roche; SERVIER
 
Antonio Sa Cunha
Honoraria - Celgene; Merck Serono; Roche
Consulting or Advisory Role - Celgene; Merck Serono; Olympus
Travel, Accommodations, Expenses - Eumedica; Merck Serono; Novartis; Roche
 
Alain Monnereau
No Relationships to Disclose
 
Edwige Yon
No Relationships to Disclose
 
Emmanuelle Bignon
No Relationships to Disclose
 
Cécile Droz-Perroteau
No Relationships to Disclose
 
Pernelle Noize
No Relationships to Disclose
 
Nicholas Moore
Consulting or Advisory Role - Merck Serono
Research Funding - Aptalis (Inst); AstraZeneca (Inst); Bayer (Inst); Biogen (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Janssen-Cilag (Inst); Lundbeck (Inst); Merck (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); RTI Health Solutions (Inst); Sanofi/Aventis (Inst)
 
Annie Fourrier-Réglat
No Relationships to Disclose